Change in CF Treatment Patterns in UK Seen With Use of Kalydeco

Change in CF Treatment Patterns in UK Seen With Use of Kalydeco

308911

Change in CF Treatment Patterns in UK Seen With Use of Kalydeco

Since the introduction of Kalydeco (ivacaftor) in the U.K., marked changes in treatment patterns for cystic fibrosis (CF) patients using the medication have become noticeable over time, a study reported. Specifically, people treated with Kalydeco were less likely to continue with other treatments, such as inhaled antibiotics or Pulmozyme (dornase alfa). The study “Treatment patterns in people with cystic fibrosis: have they changed since the introduction of ivacaftor?” was published in the Journal of Cystic Fibrosis.…

You must be logged in to read/download the full post.